Key Insights

Highlights

Treatment Research

1 treatments under study, led by Levotiroxina Teva 25 Microgrammi Compresse

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

0.0%

0 terminated out of 1 trials

Late-Stage Pipeline

100%

1 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

1Total
Phase 3 (1)

Trial Status

Recruiting1

Clinical Trials (1)

Showing 1 of 1 trials
SYFeaf90fabaf104ffba6d3d4f6d6234c13Phase 3Recruiting

Randomized study to protect from radiation iatrogenic hypothyroidism patients with medulloblastoma (any stage, any biological risk) and pediatric patients with Hodgkin lymphoma and non-Hodgkin lymphoma needing radiation therapy on thyroid site - WINHYPO 2021

Showing all 1 trials

Research Network

Common Treatments

  • Levotiroxina Teva 25 Microgrammi Compresse1

Active Sponsors

  • Fondazione IRCCS Istituto Nazionale Dei Tumori1

Related Conditions

  • Medulloblastoma1

Activity Timeline